Literature DB >> 23496265

Which is a better treatment for hypertensive patients with diabetes: a combination of losartan and hydrochlorothiazide or a maximum dose of losartan?

Haruo Nishimura1, Mitsuyo Shintani, Koji Maeda, Kentaro Otoshi, Masahiro Fukuda, Joji Okuda, Shigeo Nishi, Shinichiro Ohashi, Sumiko Kato, Yasuto Baba.   

Abstract

BACKGROUND: This 12-month study compared the effects of a combination of losartan 50 mg and hydrochlorothiazide 12.5 mg with a maximum dose of losartan (100 mg) in hypertensive patients with diabetes.
METHODS: This was a multicenter randomized open-label study.
RESULTS: A similar reduction in systolic/diastolic blood pressure from baseline to month 3 was observed in both groups. There was also a similar decrease in UACR in both groups. A significant decrease in uric acid was observed in the maximum-dose group only. eGFR decreased in the combination group after 1 year.
CONCLUSIONS: The combination of losartan and a diuretic may be a useful option in such hypertensive patients with diabetes, provided that metabolic parameters are closely monitored. In patients with hyperuricemia and impaired renal function, a maximum dose of losartan may be more beneficial.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23496265     DOI: 10.3109/10641963.2013.776564

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  2 in total

1.  Applying a "Big Data" Literature System to Recommend Antihypertensive Drugs for Hypertension Patients with Diabetes Mellitus.

Authors:  Jing-Xian Shu; Ying Li; Ting He; Ling Chen; Xue Li; Lin-Lin Zou; Lu Yin; Xiao-Hui Li; An-Li Wang; Xing Liu; Hong Yuan
Journal:  Med Sci Monit       Date:  2018-01-07

Review 2.  Thiazide Diuretic-Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials.

Authors:  Jill J Hall; Dean T Eurich; Danielle Nagy; Lisa Tjosvold; John-Michael Gamble
Journal:  J Gen Intern Med       Date:  2020-03-10       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.